BFA
ARIA

BlackRock Fund Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

BlackRock Fund Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$111M Buy
8,959,423
+889,020
+11% +$10.7M 0.02% 1118
2016
Q3 		$110M Buy
8,070,403
+238,384
+3% +$2.39M 0.02% 983
2016
Q2 		$57.9M Sell
7,832,019
-48,839
-0.6% -$366K 0.01% 1392
2016
Q1 		$50.4M Sell
7,880,858
-115,783
-1% -$649K 0.01% 1450
2015
Q4 		$50M Sell
7,996,641
-232,150
-3% -$1.52M 0.01% 1467
2015
Q3 		$48.1M Sell
8,228,791
-50,515
-0.6% -$389K 0.01% 1453
2015
Q2 		$68.5M Sell
8,279,306
-83,732
-1% -$740K 0.02% 1297
2015
Q1 		$68.9M Buy
8,363,038
+417,084
+5% +$3.08M 0.02% 1278
2014
Q4 		$54.6M Buy
7,945,954
+669,032
+9% +$4.18M 0.01% 1403
2014
Q3 		$39.3M Buy
7,276,922
+837,137
+13% +$4.89M 0.01% 1517
2014
Q2 		$41M Buy
6,439,785
+2,832,609
+79% +$19.5M 0.01% 1534
2014
Q1 		$29.1M Hold
3,607,176
– – 0.01% 1785
2013
Q4 		$24.6M Sell
3,607,176
-123,460
-3% -$667K 0.01% 1865
2013
Q3 		$68.6M Buy
3,730,636
+334,816
+10% +$6.5M 0.02% 1056
2013
Q2 		$59.4M Buy
+3,395,820
New +$60.2M 0.02% 1076

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's ARIA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Ariad Pharmaceuticals Inc (ARIA) stake by 11% in Q4 2016, buying an estimated $10.7M and bringing the position to 8,959,423 shares worth $111M. The position accounts for 0.02% of the portfolio, ranked #1118.

BlackRock Fund Advisors first reported a position in ARIA in Q2 2013 and has held it in 15 quarters since. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • BlackRock Fund Advisors held 8,959,423 shares of Ariad Pharmaceuticals Inc worth $111M as of Q4 2016.
  • BlackRock Fund Advisors bought 889,020 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $10.7M.
  • Ariad Pharmaceuticals Inc made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1118 holding.
  • BlackRock Fund Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.